SCHEMBL5852079

SCHEMBL5852079

Cc1ccc(S(=O)(=O)N(C)C2(C(=O)O)CCCC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.49
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
MAPT P10636 1/20 0.44
MCOLN3 Q8TDD5 1/20 0.44
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
C5AR1 P21730 1/20 0.41
AGER Q15109 1/20 0.41
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GLA P06280 1/20 0.40
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644793 0.83 PLAU (0.46) PLAUSMN1; SMN2KEAP1NFE2L2L3MBTL1
SCHEMBL16013722 0.80 KMT2A (0.51) PLAUKMT2ASMN1; SMN2KEAP1NFE2L2
SCHEMBL16057871 0.75 RAB9A (0.44) KMT2ASMN1; SMN2CA12CA9MAPT
SCHEMBL6502911 0.75 ADAM17 (0.54) PLAU
SCHEMBL5850857 0.75 ITGB1 (0.64) CA12CA9ALDH1A1
SCHEMBL7408145 0.73 KMT2A (0.46) KMT2ASMN1; SMN2CA12CA9MAPT
SCHEMBL13898992 0.73 MCL1 (0.50) SMN1; SMN2HTT
SCHEMBL27183093 0.71 KMT2A (0.61) KMT2ASMN1; SMN2CYP2C19ALDH1A1HPGD
SCHEMBL7410460 0.71 MAPT (0.45) KMT2ASMN1; SMN2CA12CA9MAPT
SCHEMBL642883 0.71 ALDH1A1 (0.43) SMN1; SMN2MAPTKEAP1NFE2L2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US disclosed
EP-0994895-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-04-26 EP disclosed
WO-1999006435-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed